[144] GDEV Inc. SEC Filing
Form 144 filed for proposed sale of securities. The filing discloses a proposed sale of 7,630 shares of Common Stock with an aggregate market value of $116,357.50, with an approximate sale date of 09/09/2025 on NASDAQ through Vanguard Brokerage Services. The shares were acquired as grants from Andrew Sheppard: 2,409 shares on 10/18/2023 and 5,221 shares on 06/10/2025, both described as earned through directorship. The filing reports no securities sold in the past three months and includes the standard representation that the seller is not aware of undisclosed material adverse information.
Depositata la Form 144 per la vendita proposta di titoli. La comunicazione indica una vendita proposta di 7.630 azioni di Common Stock per un valore complessivo di $116.357,50, con data di vendita approssimativa 09/09/2025 su NASDAQ tramite Vanguard Brokerage Services. Le azioni sono state assegnate da Andrew Sheppard: 2.409 azioni il 18/10/2023 e 5.221 azioni il 10/06/2025, entrambe indicate come conseguite per ruolo di amministratore. La comunicazione segnala nessuna vendita di titoli negli ultimi tre mesi e contiene la dichiarazione standard che il venditore non è a conoscenza di informazioni materiali negative non divulgate.
Presentada la Form 144 por la venta propuesta de valores. El informe revela una venta propuesta de 7.630 acciones de Common Stock con un valor de mercado agregado de $116.357,50, con fecha aproximada de venta 09/09/2025 en NASDAQ a través de Vanguard Brokerage Services. Las acciones fueron otorgadas por Andrew Sheppard: 2.409 acciones el 18/10/2023 y 5.221 acciones el 10/06/2025, ambas descritas como ganadas por desempeño como director. El informe indica ninguna venta de valores en los últimos tres meses e incluye la representación estándar de que el vendedor no tiene conocimiento de información adversa material no divulgada.
증권 매도 예정에 대한 Form 144 제출. 제출서류는 총 시가가 $116,357.50인 보통주 7,630주 매도를 예정하고 있음을 공개하며, 매수 예정일은 대략 09/09/2025로 NASDAQ에서 Vanguard Brokerage Services를 통해 이루어질 예정입니다. 해당 주식은 Andrew Sheppard으로부터 부여되었으며: 2023/10/18에 2,409주, 2025/06/10에 5,221주가 각각 이사직 수행에 따른 취득으로 기재되어 있습니다. 제출서류는 최근 3개월 내 판매된 증권 없음을 보고하며, 판매자가 공개되지 않은 중대한 불리한 정보를 알고 있지 않다는 표준 진술을 포함합니다.
Formulaire 144 déposé pour une vente projetée de titres. Le dépôt révèle une vente projetée de 7 630 actions ordinaires pour une valeur marchande totale de 116 357,50 $, avec une date de vente approximative le 09/09/2025 sur le NASDAQ via Vanguard Brokerage Services. Les actions ont été attribuées par Andrew Sheppard : 2 409 actions le 18/10/2023 et 5 221 actions le 10/06/2025, toutes deux décrites comme acquises en raison de la fonction d’administrateur. Le dépôt indique aucune vente de titres au cours des trois derniers mois et comprend la déclaration standard selon laquelle le vendeur n’est pas au courant d’informations défavorables importantes non divulguées.
Form 144 eingereicht für geplanten Verkauf von Wertpapieren. Die Meldung gibt einen geplanten Verkauf von 7.630 Aktien der Common Stock mit einem Gesamtmarktwert von $116.357,50 an, mit einem ungefähren Verkaufsdatum am 09/09/2025 an der NASDAQ über Vanguard Brokerage Services. Die Aktien wurden als Zuteilungen von Andrew Sheppard erworben: 2.409 Aktien am 18.10.2023 und 5.221 Aktien am 10.06.2025, beide als für das Amt des Direktors erworben beschrieben. Die Meldung vermerkt keine Verkäufe von Wertpapieren in den letzten drei Monaten und enthält die übliche Erklärung, dass dem Verkäufer keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.
- Proposed sale fully disclosed with broker, share count, aggregate value, exchange, and approximate sale date
- Acquisition details provided showing grant dates, amounts, and that shares were earned through directorship
- No sales in the past three months reported for the selling person, which clarifies recent insider activity
- Issuer contact fields are blank or not provided in the filing template, limiting issuer identification inside the form content
- Number of shares outstanding reported as 0 in the securities table, which is ambiguous and may be a reporting artifact
Insights
TL;DR: Routine director equity sale notice; timing and source of shares are disclosed.
The filing is a standard Rule 144 notice documenting a director-originated equity sale. It clearly identifies the broker, planned sale date, and the grant dates and amounts, which supports transparency about insider liquidity. The representation regarding absence of undisclosed material information is included as required. The filing omits some issuer contact fields present in the template, but it still provides the core sale details investors need to track insider disposition activity.
TL;DR: Disclosure shows modest insider sale size relative to typical market activity; no prior recent sales reported.
The disclosed aggregate value of $116,357.50 for 7,630 shares indicates a relatively small insider disposition on an absolute basis. The report confirms no sales by the person in the past three months, and specifies the grants were compensation for directorships on two dates. The document is procedural and does not include performance or financial data affecting valuation; it serves primarily as compliance disclosure of an intended sale.
Depositata la Form 144 per la vendita proposta di titoli. La comunicazione indica una vendita proposta di 7.630 azioni di Common Stock per un valore complessivo di $116.357,50, con data di vendita approssimativa 09/09/2025 su NASDAQ tramite Vanguard Brokerage Services. Le azioni sono state assegnate da Andrew Sheppard: 2.409 azioni il 18/10/2023 e 5.221 azioni il 10/06/2025, entrambe indicate come conseguite per ruolo di amministratore. La comunicazione segnala nessuna vendita di titoli negli ultimi tre mesi e contiene la dichiarazione standard che il venditore non è a conoscenza di informazioni materiali negative non divulgate.
Presentada la Form 144 por la venta propuesta de valores. El informe revela una venta propuesta de 7.630 acciones de Common Stock con un valor de mercado agregado de $116.357,50, con fecha aproximada de venta 09/09/2025 en NASDAQ a través de Vanguard Brokerage Services. Las acciones fueron otorgadas por Andrew Sheppard: 2.409 acciones el 18/10/2023 y 5.221 acciones el 10/06/2025, ambas descritas como ganadas por desempeño como director. El informe indica ninguna venta de valores en los últimos tres meses e incluye la representación estándar de que el vendedor no tiene conocimiento de información adversa material no divulgada.
증권 매도 예정에 대한 Form 144 제출. 제출서류는 총 시가가 $116,357.50인 보통주 7,630주 매도를 예정하고 있음을 공개하며, 매수 예정일은 대략 09/09/2025로 NASDAQ에서 Vanguard Brokerage Services를 통해 이루어질 예정입니다. 해당 주식은 Andrew Sheppard으로부터 부여되었으며: 2023/10/18에 2,409주, 2025/06/10에 5,221주가 각각 이사직 수행에 따른 취득으로 기재되어 있습니다. 제출서류는 최근 3개월 내 판매된 증권 없음을 보고하며, 판매자가 공개되지 않은 중대한 불리한 정보를 알고 있지 않다는 표준 진술을 포함합니다.
Formulaire 144 déposé pour une vente projetée de titres. Le dépôt révèle une vente projetée de 7 630 actions ordinaires pour une valeur marchande totale de 116 357,50 $, avec une date de vente approximative le 09/09/2025 sur le NASDAQ via Vanguard Brokerage Services. Les actions ont été attribuées par Andrew Sheppard : 2 409 actions le 18/10/2023 et 5 221 actions le 10/06/2025, toutes deux décrites comme acquises en raison de la fonction d’administrateur. Le dépôt indique aucune vente de titres au cours des trois derniers mois et comprend la déclaration standard selon laquelle le vendeur n’est pas au courant d’informations défavorables importantes non divulguées.
Form 144 eingereicht für geplanten Verkauf von Wertpapieren. Die Meldung gibt einen geplanten Verkauf von 7.630 Aktien der Common Stock mit einem Gesamtmarktwert von $116.357,50 an, mit einem ungefähren Verkaufsdatum am 09/09/2025 an der NASDAQ über Vanguard Brokerage Services. Die Aktien wurden als Zuteilungen von Andrew Sheppard erworben: 2.409 Aktien am 18.10.2023 und 5.221 Aktien am 10.06.2025, beide als für das Amt des Direktors erworben beschrieben. Die Meldung vermerkt keine Verkäufe von Wertpapieren in den letzten drei Monaten und enthält die übliche Erklärung, dass dem Verkäufer keine nicht offengelegten wesentlichen negativen Informationen bekannt sind.
FAQ
What insider sale does the GDEV Form 144 disclose?
Through which broker and exchange will the GDEV sale occur?
When and how were the securities being sold acquired?
Has the selling person sold any issuer securities in the past three months?
Does the filer state they possess undisclosed material information about the issuer?
